Tau in the brain interstitial fluid is fragmented and seeding–competent

[1]  L. Buée,et al.  Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody , 2019, Brain : a journal of neurology.

[2]  D. Ehrnhoefer,et al.  A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain , 2019, Acta Neuropathologica Communications.

[3]  D. Ehrnhoefer,et al.  Asparagine endopeptidase cleaves tau at N167 after uptake into microglia , 2019, Neurobiology of Disease.

[4]  D. Holtzman,et al.  The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans , 2019, Science.

[5]  E. Sigurdsson,et al.  Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau , 2018, Alzheimer's & dementia.

[6]  M. Vandermeeren,et al.  Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo. , 2018, Journal of Alzheimer's disease : JAD.

[7]  Brian A. Gordon,et al.  Tau Kinetics in Neurons and the Human Central Nervous System , 2018, Neuron.

[8]  D. Selkoe,et al.  Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles , 2018, International journal of molecular sciences.

[9]  D. Holtzman,et al.  Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy , 2017, Science Translational Medicine.

[10]  T. Montine,et al.  Seed‐competent high‐molecular‐weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients , 2016, Annals of neurology.

[11]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[12]  A. Hill,et al.  Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner , 2016, The Journal of Biological Chemistry.

[13]  P. Szekeres,et al.  Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau , 2016, The Journal of Neuroscience.

[14]  J. Ávila,et al.  Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo. , 2015, Journal of Alzheimer's disease : JAD.

[15]  B. Hyman,et al.  Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain , 2015, Nature Communications.

[16]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[17]  D. Selkoe,et al.  C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death , 2015, The Journal of Neuroscience.

[18]  Guixiang Xu,et al.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. , 2015, Brain : a journal of neurology.

[19]  M. Diamond,et al.  Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation* , 2015, The Journal of Biological Chemistry.

[20]  G. Parry,et al.  Human secreted tau increases amyloid-beta production , 2015, Neurobiology of Aging.

[21]  D. Holtzman,et al.  Anti-tau antibody reduces insoluble tau and decreases brain atrophy , 2015, Annals of clinical and translational neurology.

[22]  M. Diamond,et al.  Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target* , 2014, The Journal of Biological Chemistry.

[23]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[24]  M. Citron,et al.  Constitutive secretion of tau protein by an unconventional mechanism , 2012, Neurobiology of Disease.

[25]  D. Holtzman,et al.  Trans-cellular Propagation of Tau Aggregation by Fibrillar Species* , 2012, The Journal of Biological Chemistry.

[26]  D. Holtzman,et al.  In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice , 2011, The Journal of Neuroscience.

[27]  R. Crowther,et al.  Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: Effects on axonal viability , 2011, Neurobiology of Aging.

[28]  E. Alleva,et al.  Early behavioural markers of disease in P301S tau transgenic mice , 2010, Behavioural Brain Research.

[29]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[30]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[31]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[32]  E. Mandelkow,et al.  Additional file 5: Figure S5. of The release and trans-synaptic transmission of Tau via exosomes , 2017 .

[33]  Bradley T. Hyman,et al.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease , 2014, Acta Neuropathologica.

[34]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[35]  C. Bartram,et al.  Brief Definitive Report , 2003 .

[36]  Y. Barde,et al.  Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.

[37]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.